Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer

Adoptive T-cell therapy using high-affinity T-cell receptors (TCR) to target tumor antigens has potential for improving outcomes in high-grade serous ovarian cancer (HGSOC) patients. Ovarian tumors develop a hostile, multicomponent tumor microenvironment containing suppressive cells, inhibitory liga...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer immunology research Jg. 7; H. 9; S. 1412
Hauptverfasser:	Anderson, Kristin G, Voillet, Valentin, Bates, Breanna M, Chiu, Edison Y, Burnett, Madison G, Garcia, Nicolas M, Oda, Shannon K, Morse, Christopher B, Stromnes, Ingunn M, Drescher, Charles W, Gottardo, Raphael, Greenberg, Philip D
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.09.2019
Schlagworte:	Animals Antigens, Neoplasm - genetics Antigens, Neoplasm - immunology CD8-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - metabolism Cell Line, Tumor Cytotoxicity, Immunologic Disease Models, Animal Female Gene Expression Gene Expression Profiling Genetic Engineering GPI-Linked Proteins - genetics GPI-Linked Proteins - immunology HLA-A Antigens - genetics HLA-A Antigens - immunology Humans Immunophenotyping Immunotherapy, Adoptive - adverse effects Immunotherapy, Adoptive - methods Mesothelin Mice Neoplasm Grading Neoplasm Staging Ovarian Neoplasms - genetics Ovarian Neoplasms - mortality Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Prognosis Receptors, Antigen, T-Cell - genetics Receptors, Antigen, T-Cell - metabolism Receptors, Chimeric Antigen - genetics Receptors, Chimeric Antigen - metabolism T-Lymphocytes - immunology T-Lymphocytes - metabolism Treatment Outcome Xenograft Model Antitumor Assays
ISSN:	2326-6074, 2326-6074
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!